These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7799495)

  • 41. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
    Szeto KL; Devlin NJ
    Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
    Moger TA; Bjørnelv GM; Aas E
    Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsured.
    Malin JL; Keeler E; Wang C; Brook R
    Breast Cancer Res Treat; 2002 Jul; 74(2):143-53. PubMed ID: 12186375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening mammography: increasing the effort toward breast cancer detection.
    Hamwi DA
    Nurse Pract; 1990 Dec; 15(12):27, 30-2. PubMed ID: 2284059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Costs and cost-effectiveness of a church-based intervention to promote mammography screening.
    Stockdale SE; Keeler E; Duan N; Derose KP; Fox SA
    Health Serv Res; 2000 Dec; 35(5 Pt 1):1037-57. PubMed ID: 11130802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.
    Shirvani SM; Jiang J; Likhacheva A; Hoffman KE; Shaitelman SF; Caudle A; Buchholz TA; Giordano SH; Smith BD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):605-16. PubMed ID: 27034179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
    de Koning HJ; Heijnsdijk EA
    J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is screening mammography routinely indicated for women between 40 and 50 years of age? An affirmative view.
    Dodd GD
    J Fam Pract; 1988 Sep; 27(3):313-6. PubMed ID: 3138382
    [No Abstract]   [Full Text] [Related]  

  • 49. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
    [No Abstract]   [Full Text] [Related]  

  • 50. Breast cancer screening among women younger than age 50: a current assessment of the issues.
    Smith RA
    CA Cancer J Clin; 2000; 50(5):312-36. PubMed ID: 11075240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
    Butler JR; Furnival CM; Hart RF
    Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review.
    Barratt AL; Les Irwig M; Glasziou PP; Salkeld GP; Houssami N
    Med J Aust; 2002 Mar; 176(6):266-71. PubMed ID: 11999259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Economic evaluation of breast cancer treatment: considering the value of patient choice.
    Polsky D; Mandelblatt JS; Weeks JC; Venditti L; Hwang YT; Glick HA; Hadley J; Schulman KA
    J Clin Oncol; 2003 Mar; 21(6):1139-46. PubMed ID: 12637482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do vouchers improve breast cancer screening rates? Results from a randomized trial.
    Stoner TJ; Dowd B; Carr WP; Maldonado G; Church TR; Mandel J
    Health Serv Res; 1998 Apr; 33(1):11-28. PubMed ID: 9566175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness analysis of interventions to enhance mammography compliance using computer modeling (CAN*TROL).
    Wu JH; Fung MC; Chan W; Lairson DR
    Value Health; 2004; 7(2):175-85. PubMed ID: 15164807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer detection: improving the efficacy of screening mammography.
    Brecheisen NL; Snyder TE
    Kans Med; 1994 Apr; 95(4):90-3. PubMed ID: 8041052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark.
    Bech M; Gyrd-Hansen D
    Health Policy; 2000 Nov; 54(2):125-41. PubMed ID: 11094266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An introduction to economic issues in breast imaging.
    Farria D; Feig SA
    Radiol Clin North Am; 2000 Jul; 38(4):825-42. PubMed ID: 10943280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.
    de Koning HJ; van Ineveld BM; van Oortmarssen GJ; de Haes JC; Collette HJ; Hendriks JH; van der Maas PJ
    Int J Cancer; 1991 Oct; 49(4):531-7. PubMed ID: 1917154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cost-benefit analysis in mammography screening].
    von Fournier D
    Radiologe; 1996 Apr; 36(4):300-5. PubMed ID: 8677322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.